Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06270680 · ClinicalTrials.gov registry record · Early Phase 1
Carotenoids for Collision Athletes
A Early Phase 1 study, sponsored by Penn State University.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 31
- Enrollment target
NCT06270680 is a Early Phase 1 study that has completed, run by Penn State University. The registered enrollment target is 31 participants.
The verdict
NCT06270680, a Early Phase 1 study, has completed, sponsored by Penn State University.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 31 participants
- Enrollment target
Study Summary
This is a supplement study being conducted to find out if collision sport athletes who are exposed to repetitive head impacts while supplementing with carotenoids will have decreased pro-inflammatory blood biomarkers, increases in macular pigment optical density, improved contrast sensitivity, greater retinal nerve fiber thickness, and better overall visual quality of life scores compared to collision athletes taking a placebo.
Interventions
- OTHER Placebo
- DRUG Vision Edge Pro
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2024-08-01 |
| Est. Completion | 2024-11-22 |
| Phase | Early Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06270680
The ClinicalTrials.gov registry entry for NCT06270680 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Penn State University, which has 219 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT06270680 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06270680 about?
NCT06270680 is a clinical study titled "Carotenoids for Collision Athletes". This is a supplement study being conducted to find out if collision sport athletes who are exposed to repetitive head impacts while supplementing with carotenoids will have decreased pro-inflammatory blood biomarkers, increases in macular pigment optical density, improved contrast sensitivity, great...
What is the current status of trial NCT06270680?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 31 participants. The study started on 2024-08-01. Estimated completion is 2024-11-22.
What interventions are being tested in trial NCT06270680?
The interventions under investigation include: Placebo (OTHER), Vision Edge Pro (DRUG).
Who is sponsoring clinical trial NCT06270680?
This trial is sponsored by Penn State University, which has 219 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.